Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.3400 (0.6%) ($3.3400 - $3.3400) on Fri. Jan. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.42% (three month average) | RSI | 19 | Latest Price | $3.3400(0.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.7% a day on average for past five trading days. | Weekly Trend | CGEN declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) ARKK(82%) ARKG(81%) IBUY(81%) IWO(81%) | Factors Impacting CGEN price | CGEN will decline at least -2.21% in a week (0% probabilities). VIXM(-72%) VXX(-53%) UUP(-27%) UNG(-14%) EDOC(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.21% (StdDev 4.42%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.02(-489.82%) | Resistance Level | $3.9 | 5 Day Moving Average | $3.48(-4.02%) | 10 Day Moving Average | $3.62(-7.73%) | 20 Day Moving Average | $3.9(-14.36%) | To recent high | -53.4% | To recent low | 0.6% | Market Cap | $276m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |